INPPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.787800E-02
Normal-vs-Stage2
2.203400E-01
Normal-vs-Stage3
8.721500E-02
Normal-vs-Stage4
2.341200E-01
Stage1-vs-Stage2
3.740000E-01
Stage1-vs-Stage3
3.755200E-01
Stage1-vs-Stage4
5.767800E-01
Stage2-vs-Stage3
1.060570E-01
Stage2-vs-Stage4
8.065000E-01
Stage3-vs-Stage4
3.196200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.715600E-01
Normal-vs-AfricanAmerican
4.289800E-01
Normal-vs-Asian
5.099800E-01
Caucasian-vs-AfricanAmerican
9.165200E-01
Caucasian-vs-Asian
5.641200E-01
AfricanAmerican-vs-Asian
7.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.751180E-01
Normal-vs-Female
5.408200E-01
Male-vs-Female
4.381400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.134960E-01
Normal-vs-Age(41-60Yrs)
2.581000E-01
Normal-vs-Age(61-80Yrs)
4.259800E-01
Normal-vs-Age(81-100Yrs)
1.597810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.525810E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.024200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.173200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.911400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.357600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.171830E-01
Normal-vs-Daily Drinker
1.745760E-01
Normal-vs-Weekly Drinker
4.953600E-01
Normal-vs-Occasional Drinker
9.405600E-01
Normal-vs-Social Drinker
4.308000E-01
Non Drinker-vs-Daily Drinker
8.318800E-01
Non Drinker-vs-Weekly Drinker
1.636050E-01
Non Drinker-vs-Occasional Drinker
3.193200E-01
Non Drinker-vs-Social Drinker
1.334000E-01
Daily Drinker-vs-Weekly Drinker
2.695800E-01
Daily Drinker-vs-Occasional Drinker
3.619400E-01
Daily Drinker-vs-Social Drinker
2.320000E-01
Weekly Drinker-vs-Occasional Drinker
6.883000E-01
Weekly Drinker-vs-Social Drinker
9.999800E-01
Occasional Drinker-vs-Social Drinker
6.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.459200E-01
Normal-vs-Grade 2
6.716400E-01
Normal-vs-Grade 3
6.533600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.638000E-01
Grade 1-vs-Grade 3
6.584000E-01
Grade 1-vs-Grade 4
6.459200E-01
Grade 2-vs-Grade 3
6.500800E-01
Grade 2-vs-Grade 4
6.716400E-01
Grade 3-vs-Grade 4
6.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.390000E-02
Normal-vs-NonDiabetic
5.125800E-01
Diabetic-vs-NonDiabetic
1.144850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.840000E-01
Normal-vs-NoPancreatitis
3.778200E-01
Pancreatitis-vs-NoPancreatitis
1.339670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.949800E-01
Normal-vs-N1
2.236200E-01
N0-vs-N1
7.265400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.801800E-01
Normal-vs-TP53-NonMutant
3.997400E-01
TP53-Mutant-vs-TP53-NonMutant
2.619600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
